Literature DB >> 16923788

Globally distributed mycobacterial fish pathogens produce a novel plasmid-encoded toxic macrolide, mycolactone F.

Brian S Ranger1, Engy A Mahrous, Lydia Mosi, Sarojini Adusumilli, Richard E Lee, Angelo Colorni, Martha Rhodes, P L C Small.   

Abstract

Mycobacterium ulcerans and Mycobacterium marinum are closely related pathogens which share an aquatic environment. The pathogenesis of these organisms in humans is limited by their inability to grow above 35 degrees C. M. marinum causes systemic disease in fish but produces localized skin infections in humans. M. ulcerans causes Buruli ulcer, a severe human skin lesion. At the molecular level, M. ulcerans is distinguished from M. marinum by the presence of a virulence plasmid which encodes a macrolide toxin, mycolactone, as well as by hundreds of insertion sequences, particularly IS2404. There has been a global increase in reports of fish mycobacteriosis. An unusual clade of M. marinum has been reported from fish in the Red and Mediterranean Seas and a new mycobacterial species, Mycobacterium pseudoshottsii, has been cultured from fish in the Chesapeake Bay, United States. We have discovered that both groups of fish pathogens produce a unique mycolactone toxin, mycolactone F. Mycolactone F is the smallest mycolactone (molecular weight, 700) yet identified. The core lactone structure of mycolactone F is identical to that of M. ulcerans mycolactones, but a unique side chain structure is present. Mycolactone F produces apoptosis and necrosis on cultured cells but is less potent than M. ulcerans mycolactones. Both groups of fish pathogens contain IS2404. In contrast to M. ulcerans and conventional M. marinum, mycolactone F-producing mycobacteria are incapable of growth at above 30 degrees C. This fact is likely to limit their virulence for humans. However, such isolates may provide a reservoir for horizontal transfer of the mycolactone plasmid in aquatic environments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16923788      PMCID: PMC1695495          DOI: 10.1128/IAI.00970-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Genotyping Mycobacterium ulcerans and Mycobacterium marinum by using mycobacterial interspersed repetitive units.

Authors:  Pieter Stragier; Anthony Ablordey; Wayne M Meyers; Françoise Portaels
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

2.  Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.

Authors:  K M George; D Chatterjee; G Gunawardana; D Welty; J Hayman; R Lee; P L Small
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

Review 3.  Mycobacterium ulcerans infection.

Authors:  T S van der Werf; W T van der Graaf; J W Tappero; K Asiedu
Journal:  Lancet       Date:  1999-09-18       Impact factor: 79.321

4.  A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin.

Authors:  Armand Mve-Obiang; Richard E Lee; Edward S Umstot; Kristin A Trott; Timothy C Grammer; John M Parker; Brian S Ranger; Robert Grainger; Engu A Mahrous; P L C Small
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

5.  Identification and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR.

Authors:  T Stinear; B C Ross; J K Davies; L Marino; R M Robins-Browne; F Oppedisano; A Sievers; P D Johnson
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

6.  Mycobacterium pseudoshottsii sp. nov., a slowly growing chromogenic species isolated from Chesapeake Bay striped bass (Morone saxatilis).

Authors:  Martha W Rhodes; Howard Kator; Alan McNabb; Caroline Deshayes; Jean-Marc Reyrat; Barbara A Brown-Elliott; Richard Wallace; Kristin A Trott; John M Parker; Barry Lifland; Gerard Osterhout; Ilsa Kaattari; Kimberly Reece; Wolfgang Vogelbein; Christopher A Ottinger
Journal:  Int J Syst Evol Microbiol       Date:  2005-05       Impact factor: 2.747

7.  Mycobacterium marinum infections in fish and humans in Israel.

Authors:  M Ucko; A Colorni
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

8.  The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue.

Authors:  Tsungda Hsu; Suzanne M Hingley-Wilson; Bing Chen; Mei Chen; Annie Z Dai; Paul M Morin; Carolyn B Marks; Jeevan Padiyar; Celia Goulding; Mari Gingery; David Eisenberg; Robert G Russell; Steven C Derrick; Frank M Collins; Sheldon L Morris; C Harold King; William R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-13       Impact factor: 11.205

Review 9.  Emergence of a unique group of necrotizing mycobacterial diseases.

Authors:  K M Dobos; F D Quinn; D A Ashford; C R Horsburgh; C H King
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

10.  Mycobacterium marinum strains can be divided into two distinct types based on genetic diversity and virulence.

Authors:  Astrid M van der Sar; Abdallah M Abdallah; Marion Sparrius; Erik Reinders; Christina M J E Vandenbroucke-Grauls; Wilbert Bitter
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

View more
  47 in total

1.  Mycobacterium ulcerans causes minimal pathogenesis and colonization in medaka (Oryzias latipes): an experimental fish model of disease transmission.

Authors:  Lydia Mosi; Nadine K Mutoji; Fritz A Basile; Robert Donnell; Kathrine L Jackson; Thomas Spangenberg; Yoshito Kishi; Don G Ennis; Pamela L C Small
Journal:  Microbes Infect       Date:  2012-03-14       Impact factor: 2.700

2.  Total Synthesis of Mycolactones A and B.

Authors:  Fengbin Song; Steve Fidanze; Andrew B Benowitz; Yoshito Kishi
Journal:  Tetrahedron       Date:  2007-06-25       Impact factor: 2.457

3.  Optimized method for preparation of DNA from pathogenic and environmental mycobacteria.

Authors:  Michael Käser; Marie-Thérèse Ruf; Julia Hauser; Laurent Marsollier; Gerd Pluschke
Journal:  Appl Environ Microbiol       Date:  2008-12-01       Impact factor: 4.792

4.  Evolution of Mycobacterium ulcerans and other mycolactone-producing mycobacteria from a common Mycobacterium marinum progenitor.

Authors:  Marcus J Yip; Jessica L Porter; Janet A M Fyfe; Caroline J Lavender; Françoise Portaels; Martha Rhodes; Howard Kator; Angelo Colorni; Grant A Jenkin; Tim Stinear
Journal:  J Bacteriol       Date:  2006-12-15       Impact factor: 3.490

5.  Highly stereoselective total synthesis of fully hydroxy-protected mycolactones A and B and their stereoisomerization upon deprotection.

Authors:  Guangwei Wang; Ning Yin; Ei-ichi Negishi
Journal:  Chemistry       Date:  2011-03-15       Impact factor: 5.236

Review 6.  Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.

Authors:  Dezemon Zingue; Amar Bouam; Roger B D Tian; Michel Drancourt
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

Review 7.  Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.

Authors:  Caroline Demangel; Timothy P Stinear; Stewart T Cole
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

Review 8.  The chemistry and biology of mycolactones.

Authors:  Matthias Gehringer; Karl-Heinz Altmann
Journal:  Beilstein J Org Chem       Date:  2017-08-11       Impact factor: 2.883

9.  Chronic Mycobacterium marinum infection acts as a tumor promoter in Japanese Medaka (Oryzias latipes).

Authors:  Gregory W Broussard; Michelle B Norris; Adam R Schwindt; John W Fournie; Richard N Winn; Michael L Kent; Don G Ennis
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2008-09-24       Impact factor: 3.228

10.  Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer.

Authors:  Nicholas J Tobias; Torsten Seemann; Sacha J Pidot; Jessica L Porter; Laurent Marsollier; Estelle Marion; Franck Letournel; Tasnim Zakir; Joseph Azuolas; John R Wallace; Hui Hong; John K Davies; Benjamin P Howden; Paul D R Johnson; Grant A Jenkin; Timothy P Stinear
Journal:  PLoS Negl Trop Dis       Date:  2009-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.